Kim Blickenstaff
Net worth: 4 M $ as of 31/05/2026
Net worth: 4 M $ as of 31/05/2026
Kim D. Blickenstaff founded Alere San Diego, Inc. Currently, Mr. Blickenstaff is Chairman at Tandem Diabetes Care, Inc. Mr. Blickenstaff is also on the board of Astute Medical, Inc., Nuvation Bio Operating Co., Inc. and Nuvation Bio, Inc. Mr. Blickenstaff previously held the position of Chairman & Chief Executive Officer at Alere San Diego, Inc., Chairman & Chief Executive Officer of Biosite, Inc. (Massachusetts), Principal at Baxter Healthcare Corp. and Principal at Hybritech, Inc. Mr. Blickenstaff received an undergraduate degree from Loyola University of Chicago and an MBA from Quinlan School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 21/11/2024 | 165,190 ( 0.24% ) | 3 M $ | 31/05/2026 | |
| 21/05/2026 | 172,189 ( 0.05% ) | 823 063 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| NUVATION BIO INC. | Director/Board Member | 01/08/2019 |
| OPY ACQUISITION CORP. I | Director/Board Member | 01/10/2021 |
Astute Medical, Inc.
Astute Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Discovers and develops biomarkers for acute conditions | Director/Board Member | 12/05/2010 |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates | Director/Board Member | - |
Respiratory Motion, Inc.
Respiratory Motion, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| TANDEM DIABETES CARE, INC. | Chief Executive Officer | 01/03/2019 |
Medivation, Inc. /Old/
Medivation, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Director/Board Member | 01/01/2016 |
MediSpectra, Inc.
MediSpectra, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures medical devices | Director/Board Member | 26/03/2010 |
Amira Medical, Inc.
Amira Medical, Inc. Medical SpecialtiesHealth Technology Develops and markets glucose monitoring products | Director/Board Member | 19/09/2007 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 20 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Micro Therapeutics, Inc.
Micro Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets invasive medical devices | Health Technology |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical diagnostic instruments | Health Technology |
Hybritech, Inc.
Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Provides prostate diagnostic testing services | Commercial Services |
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Health Technology |
MediSpectra, Inc.
MediSpectra, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures medical devices | Commercial Services |
Astute Medical, Inc.
Astute Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Discovers and develops biomarkers for acute conditions | Electronic Technology |
Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for the treatment of diabetes | Health Technology |
Respiratory Motion, Inc.
Respiratory Motion, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
Amira Medical, Inc.
Amira Medical, Inc. Medical SpecialtiesHealth Technology Develops and markets glucose monitoring products | Health Technology |
DexCom, Inc.
DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
Medivation, Inc. /Old/
Medivation, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Loyola University of Chicago
Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SenoRx, Inc.
SenoRx, Inc. Medical SpecialtiesHealth Technology Develops and manufactures invasive devices for the diagnosis & treatment of breast cancer | Health Technology |
Predictive Biosciences, Inc.
Predictive Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops diagnostic products for informed cancer management | Health Services |
Biosite, Inc. (Massachusetts)
Biosite, Inc. (Massachusetts) Part of Abbott Laboratories, Biosite, Inc. is a consulting firm founded by Kenneth F. Buechler. The company, based in MA, specializes in strategic alliances, business development, and M&A advisory services within the biopharmaceutical field. The company has extensive expertise in therapeutic antibodies & proteins, oncology, autoimmune & infectious diseases, diagnostics, and specialty pharmaceuticals. Biosite, Inc. has been retained by various clients, including MedinCell S.A., Medin Cell Corp., Inc. & Undisclosed Mexican generics company, Avid Bioservices, Chiome Bioscience, Pfizer Animal Health, CombiChem, Kaken Pharmaceutical Co., Ltd., MediLite Diagnostics, Molecular Research Institute (Mri), and Structural Bioinformatics Inc. | |
Quinlan School of Business
Quinlan School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates | Health Technology |
Nuvation Bio, Inc.
Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
OPY Acquisition Corp. I
OPY Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
Select your edition
All financial news and data tailored to specific country editions